OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Stearoyl-CoA-desaturase 1 regulates lung cancer stemness via stabilization and nuclear localization of YAP/TAZ
Alessia Noto, Claudia De Vitis, Maria Elena Pisanu, et al.
Oncogene (2017) Vol. 36, Iss. 32, pp. 4573-4584
Closed Access | Times Cited: 144

Showing 1-25 of 144 citing articles:

YAP/TAZ upstream signals and downstream responses
Antonio Totaro, Tito Panciera, Stefano Piccolo
Nature Cell Biology (2018) Vol. 20, Iss. 8, pp. 888-899
Open Access | Times Cited: 828

Targeting the Hippo pathway in cancer, fibrosis, wound healing and regenerative medicine
Anwesha Dey, Xaralabos Varelas, Kun‐Liang Guan
Nature Reviews Drug Discovery (2020) Vol. 19, Iss. 7, pp. 480-494
Open Access | Times Cited: 607

Lipid metabolism in cancer: New perspectives and emerging mechanisms
Lindsay A. Broadfield, Antonino Alejandro Pane, Ali Talebi, et al.
Developmental Cell (2021) Vol. 56, Iss. 10, pp. 1363-1393
Open Access | Times Cited: 417

Interplay between YAP/TAZ and Metabolism
Ja Hyun Koo, Kun‐Liang Guan
Cell Metabolism (2018) Vol. 28, Iss. 2, pp. 196-206
Open Access | Times Cited: 352

The Hippo pathway in cancer: YAP/TAZ and TEAD as therapeutic targets in cancer
Richard Cunningham, Carsten Gram Hansen
Clinical Science (2022) Vol. 136, Iss. 3, pp. 197-222
Open Access | Times Cited: 208

Stearoyl-CoA Desaturase 1 as a Therapeutic Target for the Treatment of Cancer
Zuzanna Tracz‐Gaszewska, Paweł Dobrzyń
Cancers (2019) Vol. 11, Iss. 7, pp. 948-948
Open Access | Times Cited: 206

Emerging role of lipid metabolism alterations in Cancer stem cells
Mei Yi, Junjun Li, Shengnan Chen, et al.
Journal of Experimental & Clinical Cancer Research (2018) Vol. 37, Iss. 1
Open Access | Times Cited: 205

An Overview of Lipid Droplets in Cancer and Cancer Stem Cells
Luca Tirinato, Francesca Pagliari, Tania Limongi, et al.
Stem Cells International (2017) Vol. 2017, pp. 1-17
Open Access | Times Cited: 198

Metabolic reprogramming and its clinical implication for liver cancer
Flora Yang, Leena Hilakivi‐Clarke, Aurpita Shaha, et al.
Hepatology (2023) Vol. 78, Iss. 5, pp. 1602-1624
Open Access | Times Cited: 63

The Hippo pathway in normal development and cancer
Marcello Maugeri‐Saccà, Ruggero De Maria
Pharmacology & Therapeutics (2018) Vol. 186, pp. 60-72
Open Access | Times Cited: 159

YAP/TAZ Activation as a Target for Treating Metastatic Cancer
Janine Warren, Yuxuan Xiao, John M. Lamar
Cancers (2018) Vol. 10, Iss. 4, pp. 115-115
Open Access | Times Cited: 151

Infiltrative and drug‐resistant slow‐cycling cells support metabolic heterogeneity in glioblastoma
Lan Hoang-Minh, Florian A. Siebzehnrübl, Changlin Yang, et al.
The EMBO Journal (2018) Vol. 37, Iss. 23
Open Access | Times Cited: 148

Lipid Metabolic Reprogramming in Hepatocellular Carcinoma
Hayato Nakagawa, Yuki Hayata, Satoshi Kawamura, et al.
Cancers (2018) Vol. 10, Iss. 11, pp. 447-447
Open Access | Times Cited: 144

The role of YAP/TAZ activity in cancer metabolic reprogramming
Xiaodong Zhang, Haiying Zhao, Yan Li, et al.
Molecular Cancer (2018) Vol. 17, Iss. 1
Open Access | Times Cited: 142

Metabolism-Based Therapeutic Strategies Targeting Cancer Stem Cells
Petra Jagušt, Beatriz de Luxán‐Delgado, Beatriz Parejo-Alonso, et al.
Frontiers in Pharmacology (2019) Vol. 10
Open Access | Times Cited: 127

Metabolic features of cancer stem cells: the emerging role of lipid metabolism
Rita Mancini, Alessia Noto, Maria Elena Pisanu, et al.
Oncogene (2018) Vol. 37, Iss. 18, pp. 2367-2378
Open Access | Times Cited: 123

Dietary Fat and Cancer—Which Is Good, Which Is Bad, and the Body of Evidence
Bianka Bojková, Paweł J. Winklewski, Magdalena Wszędybył-Winklewska
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 11, pp. 4114-4114
Open Access | Times Cited: 122

Integration of Hippo-YAP Signaling with Metabolism
Consuelo Ibar, Kenneth D. Irvine
Developmental Cell (2020) Vol. 54, Iss. 2, pp. 256-267
Open Access | Times Cited: 120

Lipid metabolism alteration contributes to and maintains the properties of cancer stem cells
Huangcan Li, Zhuoying Feng, Ming‐Liang He
Theranostics (2020) Vol. 10, Iss. 16, pp. 7053-7069
Open Access | Times Cited: 118

YAP and TAZ in Lung Cancer: Oncogenic Role and Clinical Targeting
Federica Lo Sardo, Sabrina Strano, Giovanni Blandino
Cancers (2018) Vol. 10, Iss. 5, pp. 137-137
Open Access | Times Cited: 109

RASSF 1A controls tissue stiffness and cancer stem‐like cells in lung adenocarcinoma
Daniela Paňková, Yanyan Jiang, Maria Chatzifrangkeskou, et al.
The EMBO Journal (2019) Vol. 38, Iss. 13
Open Access | Times Cited: 109

Blockade of Stearoyl-CoA-desaturase 1 activity reverts resistance to cisplatin in lung cancer stem cells
Maria Elena Pisanu, Alessia Noto, Claudia De Vitis, et al.
Cancer Letters (2017) Vol. 406, pp. 93-104
Closed Access | Times Cited: 106

Page 1 - Next Page

Scroll to top